Tuesday, May 16, 2017

BRIEF-Tenax meets with FDA to discuss positive mortality data and potential levosimendan NDA submission

* Tenax meets with FDA to discuss positive mortality data and potential levosimendan NDA submission

by reutersCOMPANYNEWS via Endless Supplies .Biz - News
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)